Table 2.

Details for each participant that experienced a thrombotic or major bleed event during the study

ID	Age	Sex	BMI	Treatment	History	Positivity level*	Type	Event type	Days to event
24	40	Female	39.3	Apixaban	Stroke, DVT, PE, pregnancy loss	Single	Likely	Stroke	156
16	43	Female	36.9	Apixaban	DVT	Triple	Definite	Stroke	67
12	47	Female	19.4	Apixaban	Stroke, TIA, DVT, pregnancy loss	Double	Likely	Stroke	37
2	51	Female	25.5	Apixaban	Stroke, other arterial thrombosis, DVT, PE	Triple	Definite	Stroke	316
32	66	Male	39.3	Apixaban	DVT	N/A	Historical	Stroke	104
3	69	Female	23.2	Apixaban	Stroke, pregnancy loss	N/A	Historical	Stroke	6
27	62	Female	30.5	Warfarin	Stroke, DVT, PE	N/A	Historical	Major bleed†	319

BMI, body mass index; DVT, deep vein thrombosis; N/A, not applicable as historical APS; PE, pulmonary embolism; TIA, transient ischemic attack.

^*Refers to whether the patient’s laboratory markers denote single-, double-, or triple-positivity for antiphospholipid syndrome.

^†Vaginal hemorrhage.